Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation1-Reference-Cited by-同舟云学术

Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation1

Published:2013-03-01 Issue:3 Volume:88 Page:
ISSN:0006-3363
Container-title:Biology of Reproduction
language:en
Short-container-title:

Author:

Ahmadimoghaddam Davoud,Zemankova Lenka,Nachtigal Petr,Dolezelova Eva,Neumanova Zuzana,Cerveny Lukas,Ceckova Martina,Kacerovský Marian,Micuda Stanislav,Staud Frantisek

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,General Medicine,Reproductive Medicine

Link

http://academic.oup.com/biolreprod/article-pdf/88/3/55

Reference39 articles.

1. Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure;J Drug Target,2012

2. The significance of ABC transporters in human placenta for the exposure of the fetus to xenobiotics,2011

3. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications;Pharm Res,2007

4. Xenobiotic, bile acid, and cholesterol transporters: function and regulation;Pharmacol Rev,2010

5. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics;Br J Pharmacol,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin inhibits OCT3-mediated serotonin transport in the placenta;Biomedicine & Pharmacotherapy;2024-10

2. A Data-Driven Computational Framework for Assessing the Risk of Placental Exposure to Environmental Chemicals;Environmental Science & Technology;2024-04-26

3. Indole-3-carboxaldehyde alleviates cisplatin-induced acute kidney injury in mice by improving mitochondrial dysfunction via PKA activation;Food and Chemical Toxicology;2024-04

4. Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022;Expert Review of Clinical Pharmacology;2024-01-25

5. A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy;Pharmaceutics;2023-11-15